伦敦生物技术初创公司Baseimmune近日宣布，已成功完成1130万美元的A轮融资。这笔资金将用于推进其创新的机器学习平台，旨在简化疫苗设计过程。该轮融资由MSD Global Health Innovation Fund领投，IQ Capital、Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc等投资者共同参与。据悉，Baseimmune的机器学习技术能够加速疫苗研发，提高疫苗的有效性和安全性。这项技术的应用有望在全球范围内对抗疾病，保障公共卫生安全。
Title: Baseimmune Secures $11.3 Million in Series A Funding
Keywords: Vaccine Development, Machine Learning, Biotechnology
News Content:
Baseimmune, a London-based biotechnology startup, has recently announced the successful completion of its Series A funding round, raising $11.3 million. The funding will be used to further develop the company’s innovative machine learning platform, which aims to simplify the vaccine design process. The round was led by the MSD Global Health Innovation Fund and included participation from IQ Capital, Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc. Baseimmune’s machine learning technology is designed to accelerate vaccine development, enhancing both the efficacy and safety of vaccines. The application of this technology has the potential to combat diseases worldwide and safeguard public health security.
【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/
Views: 1